Results 321 to 330 of about 457,413 (359)
Pulmonary artery thrombosis in preterm infants born to a diabetic mother: a case report. [PDF]
J Med Case RepXiangyun Y +5 more
europepmc +1 more source
Interpretable machine learning model for early morbidity risk prediction in patients with sepsis-induced coagulopathy: a multi-center study. [PDF]
Front ImmunolTan R +6 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Blood coagulation factors in the elderly
Archives of Gerontology and Geriatrics, 1989To investigate causes of the age-dependent increase of thromboembolic events, plasma coagulation parameters were determined in healthy elderly blood donors in comparison with young, and elderly diseased blood donors. Partial thromboplastin and thrombin clotting times were slightly shortened, whereas prothrombin and reptilase clotting times were ...
Thomas Vogl +4 more
openaire +3 more sources
Assay of Blood Coagulation Factors in Heparinized Blood*
Thrombosis and Haemostasis, 1964SummaryTechnics have been devised permitting assay of certain coagulation factors in blood despite the presence of heparin in the sample. In the process of developing these methods, heparin and Polybrene were added to whole blood or plasma in varions quantities and a large number of coagulation tests then performed.
Herbert A. Perkins +2 more
openaire +3 more sources
Tissue Factor Initiated Blood Coagulation
Frontiers in Bioscience, 2006Tissue factor (TF) is the cellular receptor and cofactor for blood coagulation factor (F) VII. Exposure of flowing blood to cells that express TF leads to the initiation of blood coagulation. Blood coagulation is tightly regulated to generate a local fibrin clot at the site of vascular injury without compromising blood flow in the vasculature.
Gomez, K, McVey, JH
openaire +4 more sources
Inhibitors of blood coagulation factor XIII
Analytical Biochemistry, 2020The blood coagulation factor XIII (FXIII) plays an essential role in the stabilization of fibrin clots. This factor, belonging to the class of transglutaminases, catalyzes the final step of secondary hemostasis, i.e. the crosslinking of fibrin polymers. These crosslinks protect the clots against premature fibrinolysis.
Thomas Schmitz +2 more
openaire +3 more sources
The Effect of Arvin on Blood Coagulation Factors
British Journal of Haematology, 1968The effect of Arvin on blood coagulation factors was studied both in vitro and in patients undergoing therapeutic defibrination. Clots produced in citrated or EDTA plasma were soluble in 5 M urea, but rendered insoluble by prior incubation with calcium. Clots produced in heparinized plasma were urea‐soluble, even in the presence of excess calcium ions.
William R. Bell +2 more
openaire +3 more sources
Blood coagulation factors as inflammatory mediators
Blood Cells, Molecules, and Diseases, 2005After the first observations about blood coagulation by Hippocrates, it took until the early 1900s before the classic theory of blood coagulation was presented. As more and more other coagulation factors were discovered, the four-factor coagulation scheme became more complex, but better understood, leading to the current coagulation cascade.
Saskia H. H. F. Schoenmakers +2 more
openaire +3 more sources
THE STABILITY OF COAGULATION FACTORS IN STORED BLOOD
Australian and New Zealand Journal of Surgery, 1982The complete coagulation profile of citrate phosphate dextrose (CPD) stored blood has been studied during 21 days storage at 4°C. Ten donations were studied at zero, one, seven, 14 and 21 days. One donation contained small clots and was studied separately. Activities of factors I, II, IX, XII or XIII did not deteriorate significantly.
J.V. Lloyd +3 more
openaire +3 more sources